New Products: Neuromodulation system for OAB targets tibial nerve
Neuromodulation system for overactive bladder targets tibial nerve
Dublin—Medtronic PLC has launched the NURO System, which delivers percutaneous tibial neuromodulation (PTNM) for the treatment of overactive bladder (OAB). The NURO system delivers a mild electrical pulse to the tibial nerve via a small needle that is placed in the skin near the ankle and is attached to a neurostimulator. By using neuromodulation, PTNM targets the tibial nerve and indirectly activates the central nervous system to help alleviate symptoms of OAB. The therapy is administered in physician offices during weekly 30-minute sessions over a 12-week period. Side effects associated with the NURO System include temporary mild pain or skin inflammation near the stimulation site.
For more information, visit www.medtronic.com.